Related Experiment Video
Updated: Jul 1, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Pharmacological interventions for pediatric obstructive sleep apnea (OSA): Network meta-analysis
Yuxiao Zhang1, Siqi Leng2, Qian Hu1
1Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University) Ministry of Education, Chengdu, China.
The combination of mometasone and montelukast is the most effective treatment for pediatric obstructive sleep apnea (OSA), significantly improving the apnea-hypopnea index (AHI). This finding offers a promising therapeutic option for children with OSA.
Area of Science:
- Pediatric Pulmonology
- Sleep Medicine
- Pharmacology
Background:
- Pediatric obstructive sleep apnea (OSA) significantly impacts child health and development.
- A comprehensive evaluation of pharmacological treatments for pediatric OSA is lacking.
Purpose of the Study:
- To conduct a systematic review and network meta-analysis of pharmacological interventions for pediatric OSA.
- To identify the most effective drug treatments for improving the apnea-hypopnea index (AHI) in children.
Main Methods:
- Systematic review and Bayesian network meta-analysis of 17 randomized controlled trials (RCTs) involving 1367 children.
- Searched major databases (PubMed, Web of Science, Embase, Cochrane, CNKI) from 1950 to November 2022.
- Primary outcome: improvement in AHI; secondary outcomes: adverse events and SaO2.
Main Results:
- Mometasone + Montelukast, Budesonide, and Montelukast showed significant improvements in AHI compared to placebo.
- Mometasone + Montelukast demonstrated the highest efficacy, with a WMD of -4.74 for AHI.
- Mometasone + Montelukast also achieved high SUCRA values for AHI (85.0%) and SaO2 (91.0%).
Conclusions:
- The combination of mometasone furoate nasal spray and montelukast sodium is the most effective intervention for pediatric OSA.
- Further research is warranted to assess long-term efficacy and safety of these interventions.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

